Medicare Enrolled
Dr. Sanjay Sikand, M.D.
Pulmonary Disease · Brick, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sikand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sikand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sikand
Dr. Sanjay Sikand is a pulmonary disease specialist in Brick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sikand performed 6,806 Medicare services across 2,449 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sikand received a total of $10,785 from 39 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sikand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NJ
$10,785 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,806
Medicare services
Top 2% in NJ for pulmonary disease
2,449
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~358 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,755 | $67 | $154 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
629 | $33 | $137 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
605 | $104 | $233 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
488 | $50 | $123 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
488 | $64 | $149 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
485 | $49 | $117 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
464 | $180 | $591 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
370 | $99 | $222 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
196 | $53 | $139 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 159 | $69 | $196 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $134 | $356 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $73 | $160 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
38 | $114 | $279 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
15 | $29 | $237 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
13 | $74 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,785
Total received (2018-2024)
Avg $1,541/year across 7 years
Top 13% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,772 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,848
2023
$2,382
2022
$2,732
2021
$1,065
2020
$717
2019
$1,391
2018
$651
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$443
GlaxoSmithKline, LLC.
$303
Inspire Medical Systems, Inc.
$277
Mylan Specialty L.P.
$158
Otsuka America Pharmaceutical, Inc.
$120
GENZYME CORPORATION
$101
Regeneron Healthcare Solutions, Inc.
$68
Actelion Pharmaceuticals US, Inc.
$64
Amgen Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Avadel CNS Pharmaceuticals, LLC
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
HARMONY BIOSCIENCES LLC
$39
Grifols USA, LLC
$18
Insmed, Inc.
$17
Baxter Healthcare
$15
Electromed, Inc.
$13
Vifor Pharma, Inc.
$13
United Therapeutics Corporation
$13
Top 3 companies account for 55.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,456
AstraZeneca Pharmaceuticals LP
$1,896
AstraZeneca UK Limited
$1,231
Boehringer Ingelheim Pharmaceuticals, Inc.
$712
Mylan Specialty L.P.
$661
Inspire Medical Systems, Inc.
$615
Actelion Pharmaceuticals US, Inc.
$522
Philips Electronics North America Corporation
$358
GENZYME CORPORATION
$285
Insmed, Inc.
$251
Genentech USA, Inc.
$196
Regeneron Healthcare Solutions, Inc.
$190
Inari Medical, Inc.
$183
Otsuka America Pharmaceutical, Inc.
$135
Takeda Pharmaceuticals U.S.A., Inc.
$114
Electromed, Inc.
$104
Baxter Healthcare
$87
Sunovion Pharmaceuticals Inc.
$71
Harmony Biosciences LLC
$70
HARMONY BIOSCIENCES LLC
$64
Amgen Inc.
$62
Avadel CNS Pharmaceuticals, LLC
$62
Grifols USA, LLC
$59
United Therapeutics Corporation
$41
Bayer HealthCare Pharmaceuticals Inc.
$40
Mallinckrodt Hospital Products Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
Circassia Pharmaceuticals Inc
$39
IDORSIA PHARMACEUTICALS US INC
$30
Jazz Pharmaceuticals Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Teva Pharmaceuticals USA, Inc.
$23
Merck Sharp & Dohme LLC
$16
Vifor Pharma, Inc.
$13
PFIZER INC.
$13
Resmed Corp
$13
CSL Behring
$13
Shire North American Group Inc
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · AirSense · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · ELIQUIS · Esbriet · FASENRA · FLOWTRIEVER CATHETER · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMRYZ · NUCALA · NUEDEXTA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · S · SAMSCA · SMARTVEST · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · WAKIX · Wakix · Wellcentive Undiv · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
44
Per 100K population
6.8
County median income
$86,411
Nearest hospital
OCEAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sikand is a mixed practice specialist, with above-average Medicare volume (top 2% in NJ), with low-engagement industry engagement in the top 13% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sikand experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Sikand performed 2,755 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sikand receive payments from pharmaceutical companies?
Yes. Dr. Sikand received a total of $10,785 from 39 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sikand's costs compare to other pulmonary diseases in Brick?
Dr. Sikand's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sikand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Brick
Browse pulmonary diseases in Brick ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology